Recent Articles from GlobeNewswire

GPK Investors Have Opportunity to Lead Graphic Packaging Holding Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Graphic Packaging Holding Company (“Graphic Packaging” or “the Company”) (NYSE: GPK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
CVLT Investors Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Commvault Systems, Inc. (“Commvault” or “the Company”) (NASDAQ: CVLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FS KKR Capital Corp. (“FSK” or “the Company”) (NYSE: FSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
Adstra Recognized as "One to Watch" in Snowflake's Modern Marketing Data Stack Report
Adstra fuels success in Data & Identity through collaboration with Snowflake AI Data Cloud
By Adstra LLC · Via GlobeNewswire · June 22, 2026
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
Heilind Electronics Now Stocking Hirose DF22 Series Compact Branch Connectors for High-Current Power Distribution Applications
Simplify wiring, reduce system cost, and streamline power distribution in medical, industrial, and robotics designs with Hirose's compact, versatile branching solution
By Heilind Electronics · Via GlobeNewswire · June 22, 2026
UNSTOPPABLE: NOBLIS CLINCHES TOP D.C. WORKPLACE DISTINCTION FOR 13TH CONSECUTIVE YEAR
Proof positive that technical talent, culture, and mission serve the public good
By Noblis, Inc. · Via GlobeNewswire · June 22, 2026
Teamshares to participate in Northland Growth Conference on June 23, 2026
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Teamshares, a tech-enabled acquiror of SMEs, announced today it will participate in the Northland Growth Conference, being held virtually on June 23, 2026. As previously announced, Teamshares’ common stock ticker is also expected to change from LOKV to TMS the same day.
By Teamshares Inc. · Via GlobeNewswire · June 22, 2026
NTHU Researchers Develop World’s Brightest Single-Photon Source for Quantum Technologies
HSINCHU, Taiwan, June 22, 2026 (GLOBE NEWSWIRE) -- A research team led by Professor Hao-Wu Lin from the Department of Materials Science and Engineering at National Tsing Hua University (NTHU) has developed the world’s brightest room-temperature single-photon source, which uniquely combines ultrafast and non-blinking emission. The device emits more than 2.3 billion photons per second, setting a new global benchmark and marking a significant milestone toward practical quantum communication and integrated quantum photonic chips. This breakthrough has been published in Science Advances.
By NATIONAL TSING HUA UNIVERSITY · Via GlobeNewswire · June 22, 2026
Acute Stroke Time Metrics Improve When the Right Protocols Are in Place. A New Peer-Reviewed Study Documents Exactly How Much.
Research spanning 79 hospitals and 14 states shows EMS pre-notification alone closes a 20-point performance gap in door-to-needle times under 60 minutes
By TeleSpecialists · Via GlobeNewswire · June 22, 2026
Dogfish Head & Rolling Stone Celebrate 250 Years of American Music with Exclusive Whiskey Collaboration
MILTON, Del., June 22, 2026 (GLOBE NEWSWIRE) -- A duet for the ages, Dogfish Head and Rolling Stone celebrate 250 years of American music with an exclusive whiskey collaboration. Similar to the makings of a great song, the Dogfish Head x Rolling Stone Whiskey is layered with sensory nuances, blending whiskey and brandy matured in 12 different barrel types, including Dogfish Head whiskey and brandy barrels and Samuel Adams Utopias barrels, to create a complex and uniquely American whiskey. At 90 proof (45% ABV), this new, five-year-aged American single malt whiskey delivers layered flavor and character while maintaining a smooth finish.
By Dogfish Head Craft Brewery · Via GlobeNewswire · June 22, 2026
POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against POET Technologies Inc. (“POET” or “the Company”) (NASDAQ: POET) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SES AI Corporation (“SES” or “the Company”) (NYSE: SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
BrewDog Bars Draw Record Fan Turnout as Global Tournament Fever Drives Double-Digit Growth
Fans pack BrewDog bars for world-class football, ice-cold beer, American craft favourites, and a cool escape from the summer heat
By Tilray Brands, Inc. · Via GlobeNewswire · June 22, 2026
iQor Opens New Cairo Delivery Hub, Expanding Global CX Reach Across EMEA and Beyond
New Egypt Operations Launch With 500 Seats, 5-Year Plan to Reach 5,000 Employees, Backed by ITIDA and MCIT Partnership
By iQor US Inc. · Via GlobeNewswire · June 22, 2026
GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globant S.A. (“Globant” or “the Company”) (NYSE: GLOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · June 22, 2026
Matrix Applications Reaffirms BBB Accreditation
New York, NY, June 22, 2026 (GLOBE NEWSWIRE) -- Matrix Applications, a leading provider of financial technology and operational solutions in the capital markets, marks its fourth year earning accreditation from the Better Business Bureau (BBB), a nonprofit organization dedicated to advancing marketplace trust by holding businesses to high standards of ethical conduct, accountability and customer care.
By Matrix Applications LLC · Via GlobeNewswire · June 22, 2026
Paychex Named One of America's Most Trustworthy Companies by Newsweek
Paychex also earned Newsweek’s America’s Greatest Workplaces honor
By Paychex, Inc. · Via GlobeNewswire · June 22, 2026
CurePSP Expands Grant Program with $155,000 Investment in Studying Care for Rare Neurological Diseases
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- CurePSP announced the latest recipients of the Collaborative Approaches to Resources, Education and Support (CARES) grants, awarding a total of $155,000 to four projects spanning seven leading medical institutions in the U.S. and Canada.
By CurePSP · Via GlobeNewswire · June 22, 2026
Enstar Group Limited Announces Any And All Cash Tender Offer For Junior Subordinated Notes Due 2042
HAMILTON, Bermuda, June 22, 2026 (GLOBE NEWSWIRE) -- Enstar Group Limited (“Enstar” or the “Offeror”) today announced that it has commenced a cash tender offer (the “Offer”) for any and all of the outstanding 5.500% Fixed-Rate Reset Junior Subordinated Notes due 2042 issued by Enstar’s wholly owned subsidiary, Enstar Finance LLC, that Enstar guarantees on a junior subordinated basis (the “Notes”). The Offer is being made upon the terms and subject to the conditions set forth in the offer to purchase dated June 22, 2026 (the “Offer to Purchase”).
By Enstar Group Limited · Via GlobeNewswire · June 22, 2026
DEADLINE APPROACHING: Berger Montague Advises SES AI Corporation (NYSE: SES) Investors to Inquire About a Securities Fraud Class Action by June 26, 2026
PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against SES AI Corporation (NYSE: SES) (“SES AI” or the “Company”) on behalf of investors who purchased or acquired SES AI securities during the period from January 29, 2025 through March 4, 2026 (the “Class Period”).
By Berger Montague · Via GlobeNewswire · June 22, 2026
Circana Releases New Research Proving the Business Value and Incrementality of Influencer Marketing
New report finds 75% of brands have room to scale influencer investment and drive additional growth
By Circana · Via GlobeNewswire · June 22, 2026
Airia Named as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Governance Platforms
For us, this recognition validates Airia's unified approach to AI security and governance with furthest position on Completeness of Vision axis
By Airia · Via GlobeNewswire · June 22, 2026
Osteopathic Medical School Applications Jump More than 12 Percent
Highest number since the pandemic year of 2021
EchoStar Changing Stocker Ticker SATS to ECHO, Marking the Company's Next Era on Earth and in Space
EchoStar Corporation is officially changing its Nasdaq stock ticker symbol from "SATS" to "ECHO" Effective June 24, 2026
By EchoStar Corporation · Via GlobeNewswire · June 22, 2026
Arms Cyber provides additional hardening for Veeam Environments with Immutable Shield, Anti-Tamper Controls, and Process Validation
New stealth-driven capabilities purpose-built for Veeam environments to shield backup data, services, and execution paths from the ransomware groups now targeting backup infrastructure directly.
By armscyber · Via GlobeNewswire · June 22, 2026
Maloney + Novotny Modernizes Assurance Practice with Fieldguide’s AI-Native Platform
Maloney + Novotny's firm-wide Assurance Modernization plan spans financial statement audit, IT attest, and advisory services, with Fieldguide’s agentic AI-native platform serving as a unified environment to support its people, client relationships, and commitment to service excellence
By Fieldguide Inc. · Via GlobeNewswire · June 22, 2026
Atlantic White Shark Conservancy and Stop & Shop Launch the Search for “Shark Marty”
Stop & Shop to release Limited-Edition White Shark Marty plushies with portion of proceeds supporting shark research, education, and conservation
By Stop and Shop · Via GlobeNewswire · June 22, 2026
Cycode Named as a Leader in the 2026 Gartner® Magic Quadrant™ for Software Supply Chain Security
Building on its origins of securing the Software Supply Chain through the natural explosion of AI, Cycode is recognized in the first ever Gartner® Magic Quadrant™ for Software Supply Chain Security, 2026 in the age of AI-driven development
By Cycode Inc · Via GlobeNewswire · June 22, 2026
DGS and Infosim® Announce First Production-Validated Integration of RF Awareness and Enterprise Network Management
This joint integration closes a longstanding visibility gap between radio-layer conditions and network operations
By Digital Global Systems · Via GlobeNewswire · June 22, 2026
Jade Launches Integrated Options Technology for Wealth Advisors
The new platform enables advisors to manage risk and generate alpha using covered calls and other option overlay strategies with greater efficiency and oversight
By Jade · Via GlobeNewswire · June 22, 2026
HUHUTECH Surpasses RMB 13.1 Million in Cumulative Project Awards from BYD-Affiliated Facilities Since 2022
Four-year relationship spans gas detection, gas monitoring, and facility-management systems across multiple manufacturing sites, with additional projects delivered in 2026
CSX Corp. Announces Date for Second Quarter Earnings Release and Earnings Call
JACKSONVILLE, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release first quarter financial and operating results after the market close on Wednesday, July 22, 2026. This will be followed by a conference call and live webcast hosted by the company’s management team at 4:30 p.m. ET.
By CSX Corporation · Via GlobeNewswire · June 22, 2026
The Atomic Comeback: Why Uranium and Nuclear Power Are Suddenly at the Center of the AI Era
Issued on behalf of Eagle Nuclear Energy Corp.
By Energy Metal News · Via GlobeNewswire · June 22, 2026
Teamshares Nasdaq ticker changing to TMS on June 23rd, replacing current LOKV ticker
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Teamshares, a tech-enabled acquiror of SMEs, previously announced its completed business combination with Live Oak Acquisition Corp. V (NASDAQ: LOKV) on June 19, 2026.
By Teamshares Inc. · Via GlobeNewswire · June 22, 2026
Micron and Anthropic Announce Strategic Agreement to Scale Next-Generation AI Infrastructure
Collaboration spans memory and storage AI architecture design, supply agreement, enterprise AI adoption and a strategic investment
By Micron Technology, Inc. · Via GlobeNewswire · June 22, 2026
Introducing Agent Architect and Agent Performance Suite for Zoom Virtual Agent
At a glance: New Zoom Virtual Agent capabilities
By Zoom Communications, Inc. · Via GlobeNewswire · June 22, 2026
Yes& Acquires Modo Modo, Expanding B2B Marketing and Atlanta Presence
ATLANTA, GA, June 22, 2026 (GLOBE NEWSWIRE) -- Yes& has acquired Modo Modo, a B2B-focused agency recognized for its work across healthcare, fintech, manufacturing, energy and technology sectors.
By Yes& · Via GlobeNewswire · June 22, 2026
NOVARC LAUNCHES NovAI AUTONOMY AS PART OF NovAI SUITE AND EXPANDS INTEGRATION TO YASKAWA AND ABB ROBOTS
Novarc’s AI-powered welding automation - featuring real-time vision, adaptive control and welding intelligence - to be demonstrated at Automate 2026
By Novarc Technologies Inc. · Via GlobeNewswire · June 22, 2026
Prosper AI raises $30M from Andreessen Horowitz to scale the first AI platform to run the entire patient journey
Working across 150,000 healthcare providers, Prosper AI is the first platform built to combine patient scheduling, insurance verification, and patient billing while coordinating voice interactions with both patients and insurers.
By Prosper AI · Via GlobeNewswire · June 22, 2026
TJO 10x10 Management’s Resorts Celebrate the Fourth of July with Onsite Fireworks, Foam Parties and a Full Week of Family Fun
HOUSTON, June 22, 2026 (GLOBE NEWSWIRE) -- This Fourth of July, the red, white and blue rolls out all week long. From June 29 through July 5, Great Escapes RV Resorts, part of the TJO 10x10 Management portfolio of outdoor hospitality destinations that includes Great Escapes, Jellystone Park™, KOA, and other affiliated properties, is lighting up the holiday with onsite fireworks, foam parties, glow parades and patriotic fun for every age, with the celebration turned up a notch for America's 250th birthday.
By TJO 10x10 Management · Via GlobeNewswire · June 22, 2026
Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health
The FDA’s second major labeling update in 16 months — after its February 2025 removal of the cardiovascular boxed warning — marks a historic modernization of how testosterone therapy is prescribed, bringing labeling in step with a decade of new clinical evidence. Marius CEO Shalin Shah, an invited speaker at the agency’s expert panel on the therapy, helped advance the earlier change.
By Marius Pharmaceuticals LLC · Via GlobeNewswire · June 22, 2026
EnduroSat Names Spencer McCollester as SVP of Operations, US
A former Palantir leader, McCollester will scale EnduroSat’s US operations as the company expands its footprint to serve defense, government, and commercial customers at scale
By EnduroSat · Via GlobeNewswire · June 22, 2026
Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise
Initiative creates new resource to support and accelerate early-stage therapeutics companies
By Parexel International LLC · Via GlobeNewswire · June 22, 2026
Syntec Optics (Nasdaq: OPTX) Secures over $4M in New BioMed Orders Across Diversified Life Sciences Platforms
ROCHESTER, NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and biomed tech today announced it received nearly $4 million in U.S. life sciences purchase orders. 
By Syntec Optics · Via GlobeNewswire · June 22, 2026
SPARC AI Registered as AUKUS Authorised User, Opening Pathway to US and UK Defence Markets
VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- SPARC AI Inc. (CSE: SPAI; OTCQB: SPAIF; Frankfurt: 5OV0) ("SPARC AI" or the "Company"), today announced it has been registered by the Australian Government as an authorized user under the AUKUS licence-free environment, a designation that lets the company move eligible defence technology to US and UK partners without a separate export permit.
By SPARC AI INC · Via GlobeNewswire · June 22, 2026
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
Melbourne, Australia, June 22, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX | OTCQB:INNMF), (“Amplia” or the “Company”) provides a letter to shareholders from CEO and Managing Director Dr. Chris Burns outlining the potential for the Company’s best-in-class FAK inhibitor narmafotinib in combination with the emerging KRAS inhibitor class following exciting new data presented at the American Society of Clinical Oncology Annual Meeting earlier this month:
By Amplia Therapeutics Limited · Via GlobeNewswire · June 22, 2026
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
Nes-Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today provided an update on its RAIN token holdings. As of June 20, 2026, the Company held 79,568,550,005 RAIN tokens with a total value of approximately $1.14 billion1.
By Enlivex Ltd. · Via GlobeNewswire · June 22, 2026
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
Live webcast on Wednesday, June 24th at 2:40 PM ET
By AIM ImmunoTech Inc. · Via GlobeNewswire · June 22, 2026
Ever.green Brings REI Co-op and Cutler Development Together to Support a New Solar Project in Marion County, South Carolina
REI Co-op and Cutler Development purchased High-Impact RECs through Ever.green, contributing to new clean electricity generation in a rural South Carolina community where energy costs consume roughly 10 percent of annual income
By Ever.green · Via GlobeNewswire · June 22, 2026
Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis
The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to submit a New Drug Application (NDA) for EB613
By Entera Bio Ltd. · Via GlobeNewswire · June 22, 2026
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP inhibitor. DDRi therapies collectively represented an estimated $7-plus billion in global sales in 2025, and the broader oncology, diagnostics and precision medicine markets are projected to climb to roughly $750 billion by 2030. New inhibitor classes are emerging as the next major wave. Sitting at the forefront of this shift is Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF), (profile) a Canadian clinical-stage oncology company developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor that targets a DNA repair enzyme involved in multiple DNA repair pathways. As the field races to find the next generation of synthetic lethality assets, Onco-Innovations occupies a unique space as it strengthens its position in the biopharmaceutical and biotechnology sector, along with other leading companies, such as AstraZeneca plc (NYSE: AZN), Aprea Therapeutics Inc. (NASDAQ: APRE), Boundless Bio Inc. (NASDAQ: BOLD) and Foghorn Therapeutics Inc. (NASDAQ: FHTX), that are focused on developing therapies for serious diseases, particularly cancer.
By BioMedWire · Via GlobeNewswire · June 22, 2026
NetworkNews Audio Announces Audio Press Release (APR) Discussing AI Infrastructure Demand Creating Urgent Need for Scalable, Intelligent Automation
AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- via IBN -- NetworkNewsAudio announces the Audio Press Release (APR) titled “AI Infrastructure Boom Drives Demand for Semiconductor, Pharmaceutical Automation,” featuring Nightfood Holdings Inc. (OTCQB: NGTF).
By NetworkNewsWire · Via GlobeNewswire · June 22, 2026
Independent Fire Testing Confirms Eos Z3 Battery System Exhibited No Thermal Runaway, No Sustained Fire, and No Propagation Under Abuse Testing; Company Receives ISO 14001 Certification
Energy Safety Response Group testing found no thermal runaway, no sustained fire, and no propagation under direct flame impingement and overcharge abuse, supporting safe siting of long-duration storage in dense urban environments
By Eos Energy Enterprises, Inc. · Via GlobeNewswire · June 22, 2026
FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
Allowed claims directly support the Company’s ongoing Phase 1/2 clinical trial of CYWC628 in patients with diabetic foot ulcers
By FibroBiologics, Inc. · Via GlobeNewswire · June 22, 2026
NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
Strong Capitalization Foundation Supports Strategic Growth and Market Stability
By NewGenIVF Group Limited · Via GlobeNewswire · June 22, 2026
Saratoga Investment Corp. to Report Fiscal First Quarter 2027 Financial Results and Hold Conference Call
NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter ended May 31, 2026, on Tuesday July 7, 2026, after market close. A conference call to discuss the financial results will be held on Wednesday July 8, 2026. Details for the conference call are provided below.
By Saratoga Investment Corp · Via GlobeNewswire · June 22, 2026
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a cure. More than 2.9 million people worldwide are living with MS today, and despite decades of research, every approved treatment falls short of the same fundamental goal: stopping the disease cold. Current therapies can slow progression, but they cannot halt it, and for millions of patients, that gap means a future of worsening disability. Now, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (profile) is challenging that reality. The company is advancing Lucid-MS, a patented, first-in-class drug candidate that takes a fundamentally different approach by directly targeting the myelin sheath that MS destroys, and this new drug candidate is preparing to enter phase 2 clinical trials. Quantum BioPharma is one of several companies focused on the development and commercialization of therapies for neurological, autoimmune and immune-mediated diseases, including Sanofi (NASDAQ: SNY), Roche Holding AG (OTCQX: RHHBY), Biogen Inc. (NASDAQ: BIIB) and Clene Inc. (NASDAQ: CLNN).
By BioMedWire · Via GlobeNewswire · June 22, 2026
Fengate’s 2025 Sustainability Report highlights responsible investment across housing, healthcare, digital infrastructure, and energy transition in North America
Toronto, ON, June 22, 2026 (GLOBE NEWSWIRE) -- Fengate Asset Management (“Fengate”) today released its 2025 Sustainability Report, detailing how the firm continues to integrate responsible investment across its infrastructure, private equity, and real estate strategies in Canada and the United States.  
By Fengate Asset Management · Via GlobeNewswire · June 22, 2026
Atlantic International Reports Record First Quarter 2026 Revenue of $249.9 Million
Circle8 Acquisition Establishes Global Workforce Solutions Platform Across North America and Europe
By Atlantic International Corp. · Via GlobeNewswire · June 22, 2026
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of treatment for all participants in Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of Alcohol Use Disorder (AUD).
By Clearmind Medicine Inc. · Via GlobeNewswire · June 22, 2026
Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
– Development Partner Torii Pharmaceutical also recently announced dosing of the first Japanese patient in this trial evaluating YCANTH (TO-208) in Japan –
By Verrica Pharmaceuticals Inc. · Via GlobeNewswire · June 22, 2026
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
The Breakthrough Therapy Designation (BTD) was granted based on the positive results from the EMBRAVE Part A trial of elsunersen
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
-- RMAT designation granted based on Phase 1/2 clinical data, including results previously published in The New England Journal of Medicine, demonstrating PM359’s potential to address unmet need in p47phox-deficient CGD --
By Prime Medicine, Inc. · Via GlobeNewswire · June 22, 2026
Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production
Refinity is developing an integrated pathway to convert mixed plastic waste into circular olefins and specialty hydrocarbon products, bypassing bio-based feedstock constraints
By Innventure, Inc. · Via GlobeNewswire · June 22, 2026
Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking Infrastructure
DALLAS, June 22, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has partnered with Blockdaemon, a leading U.S. headquartered institutional-grade crypto infrastructure company, to support their Hyperliquid staking operations through the Kinetiq X Hyperion Validator.
By Hyperion DeFi, Inc. · Via GlobeNewswire · June 22, 2026
Catheter Precision, Inc. Announces Allowance of Key Intellectual Property
Eight New Patents Issued on Heart Failure Technology
By Catheter Precision, Inc. · Via GlobeNewswire · June 22, 2026
DaySavers Launches Perfect Pack 2 Portable Joint-Filling Machine to Create Perfect Pre-Rolls On the Go
The Next Generation of DaySavers' Best-Selling Cone Filling Machine Arrives Just as Pre-Rolls Overtake Flower as Cannabis' #1 Product, Making Homemade Joints Accessible to All
By Custom Cones USA · Via GlobeNewswire · June 22, 2026
BitFuFu Announces US$5 Million Share Repurchase Program
SINGAPORE, June 22, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that on June 22, 2026, its board of directors approved a share repurchase program, pursuant to which the Company may repurchase up to US$5 million worth of its Class A ordinary shares, par value $0.0001 per share, during a 24-month period starting from June 24, 2026. The share repurchase program aims to demonstrate the Company’s confidence in its long-term business prospect and to deliver value to shareholders.
By BitFuFu Inc. · Via GlobeNewswire · June 22, 2026
Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refractory Lupus Nephritis
Phase 1/2 SSc study is expected to enroll patients at over 20 participating clinical sites in at least five countries
By Prolium Bioscience, Inc. · Via GlobeNewswire · June 22, 2026
Sonoco To Report Second Quarter 2026 Results
HARTSVILLE, S.C., June 22, 2026 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), a global leader in high-value sustainable packaging, will announce second quarter 2026 results on Wednesday, July 22, 2026 after the market closes. The Company will host a conference call to discuss these results on Thursday, July 23, 2026 at 8:00 a.m. Eastern Time.
By Sonoco Products Company · Via GlobeNewswire · June 22, 2026
Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (“Westport") (TSX:WPRT / Nasdaq: WPRT), today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 4,854,369 common shares (or pre-funded warrants in lieu thereof) in a registered direct offering and, in a concurrent private placement, warrants to purchase up to 4,854,369 common shares, priced at-the-market under Nasdaq rules. The combined effective purchase price for each common share (or pre-funded warrant in lieu thereof) and associated private placement warrant is US$2.06. The private placement warrants have an exercise price of US$2.06 per common share, will be immediately exercisable and will expire two years following the date of issuance. Subject to limited exceptions, a holder of warrants will not have the right to exercise any portion of its warrants if the holder would beneficially own in excess of 9.99% of the number of Westport common shares outstanding immediately after giving effect to such exercise.
By Westport Fuel Systems Inc. · Via GlobeNewswire · June 22, 2026
Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion
Appointments deepen operational leadership for commercial expansion and market positioning as Veea rapidly scales its AI-native edge infrastructure platform
By Veea Inc. · Via GlobeNewswire · June 22, 2026
Route 92 Medical Announces First Commercial Cases in Canada
Procedures follow Health Canada Medical Device License for the Company’s advanced neurovascular portfolio
By Route 92 Medical, Inc. · Via GlobeNewswire · June 22, 2026
Kandi Technologies Accelerates Global Expansion
Kandi’s International Off-Road Vehicle Business Reaches Customers in 35 Countries and Regions, Expanding in Africa, Southeast Asia, Latin America and the Middle East Alongside Robust Momentum in the North American Market